Callan Family Office’s Archrock AROC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$616K Buy
15,130
+98
+0.7% +$3.61K 0.01% 744
2026
Q1
$523K Sell
15,032
-1,064
-7% -$34K 0.01% 749
2025
Q4
$419K Buy
16,096
+1,494
+10% +$37.2K 0.01% 829
2025
Q3
$384K Sell
14,602
-316
-2% -$7.62K 0.01% 623
2025
Q2
$370K Buy
14,918
+3,281
+28% +$80.4K 0.01% 700
2025
Q1
$305K Hold
11,637
0.02% 422
2024
Q4
$290K Buy
+11,637
New +$270K 0.02% 491

Other funds holding AROC

Callan Family Office's AROC Position: Q2 2026 in Review

Callan Family Office increased its Archrock (AROC) stake by 0.65% in Q2 2026, buying an estimated $3.61K and bringing the position to 15,130 shares worth $616K. The position accounts for 0.01% of the portfolio, ranked #744.

Callan Family Office first reported a position in AROC in Q4 2024 and has held it in 7 quarters since. 450 funds tracked by Wall St. Rank hold AROC as of Q2 2026.

  • Callan Family Office held 15,130 shares of Archrock worth $616K as of Q2 2026.
  • Callan Family Office bought 98 Archrock shares in Q2 2026, an estimated $3.61K.
  • Archrock made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #744 holding.
  • Callan Family Office first reported a position in Archrock in Q4 2024 and has held it in 7 quarters since.
  • 450 funds tracked by Wall St. Rank held Archrock as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.